ARCHIVES

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

This article is from The Cancer Letter archive.

Vol. 23 No. 05 | February 7, 1997

Download PDF Visit The Full Archive

Related Articles

NCAB Committee Still Debating How To Encourage Surgical Oncology

April 26, 1985

NCI Advisors To Gain Increased Responsibility For Concept, Technical Merit Review Of Contracts

December 19, 1980

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

February 15, 2002

Judge Rules First Amendment Protects Distribution Of Off-Label Use Information

August 14, 1998

National Academies: Changes Required To Reduce Incidence Of Medical Errors, Report Finds

December 3, 1999

FDA News: FDA Approves Reagent System for Graft-Versus-Host Disease

January 24, 2014